These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17006401)

  • 1. Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial.
    Sadeghi-Bazargani H; Ehdaeivand F; Arshi S; Eftekhar H; Sezavar H; Amanati L
    Med Sci Monit; 2006 Oct; 12(10):CR420-5. PubMed ID: 17006401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
    Mohebbi-Kian E; Mohammad-Alizadeh-Charandabi S; Bekhradi R
    Contraception; 2014 Oct; 90(4):440-6. PubMed ID: 24981150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M; Mukherjee P; Biswas R
    Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Program- and method-related determinants of first DMPA use duration in rural Bangladesh.
    Riley AP; Stewart MK; Chakraborty J
    Stud Fam Plann; 1994; 25(5):255-67. PubMed ID: 7871551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives: knowledge and compliance].
    Koch T; Marslew U; Nielsen MR
    Ugeskr Laeger; 1993 Nov; 155(44):3546-50. PubMed ID: 8236575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
    Arias RD; Jain JK; Brucker C; Ross D; Ray A
    Contraception; 2006 Sep; 74(3):234-8. PubMed ID: 16904417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM
    Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of depo-provera in teens.
    Khoiny FE
    J Pediatr Health Care; 1996; 10(5):195-201. PubMed ID: 8920351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
    Chotnopparatpattara P; Taneepanichskul S; Treratanachat S; Charuruks N
    J Med Assoc Thai; 2003 Feb; 86(2):172-7. PubMed ID: 12678156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K; Inal MM; Ozelmas I
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent use of the monthly contraceptive injection.
    Tuchman LK; Huppert JS; Huang B; Slap GB
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):255-60. PubMed ID: 16171729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L; Denny L; Wright TC; Kuhn L
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.